| P50 | author | Carlos A. Rodriguez | Q54965244 |
| | Omar Vesga | Q59704994 |
| | Andres F. Zuluaga | Q42786332 |
| P2093 | author name string | Maria Agudelo | |
| | Yudy A Aguilar | |
| P2860 | cites work | Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: a pharmacodynamic in vitro model approach to selection of resistant populations. | Q51153157 |
| | Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli. | Q51294936 |
| | Dose-related selection of fluoroquinolone-resistant Escherichia coli. | Q54437857 |
| | Mechanisms of hyperproduction of TEM-1 beta-lactamase by clinical isolates of Escherichia coli. | Q54598789 |
| | About the validation of animal models to study the pharmacodynamics of generic antimicrobials | Q87788929 |
| | [Mortality risk factors associated with healthcare infections in a tertiary level university hospital in Colombia] | Q88161150 |
| | Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam | Q41613745 |
| | In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus. | Q41850136 |
| | Controlling antimicrobial resistance: Interfering in the process of natural selection | Q41874597 |
| | Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator | Q41890029 |
| | Fluorescent-increase kinetics of different fluorescent reporters used for qPCR depend on monitoring chemistry, targeted sequence, type of DNA input and PCR efficiency. | Q42051325 |
| | Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane | Q42109987 |
| | A standard numbering scheme for the class A beta-lactamases | Q42861944 |
| | Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots | Q43263134 |
| | Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia. | Q43288031 |
| | Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli | Q44358172 |
| | Sequences of the genes blaT-1B and blaT-2 | Q44496391 |
| | Decrease in bacterial load versus resistance selection of pneumococcal subpopulations by beta-lactam physiological concentrations over time: an in vitro pharmacodynamic simulation | Q46697531 |
| | In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation | Q46789907 |
| | Vancomycin-resistant Staphylococcus aureus | Q46908673 |
| | Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime | Q46913918 |
| | Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate | Q24564458 |
| | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications | Q24646677 |
| | Learning from agriculture: understanding low-dose antimicrobials as drivers of resistome expansion | Q27002632 |
| | Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model | Q28474000 |
| | Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum | Q30391042 |
| | Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases | Q33236887 |
| | In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin | Q33595346 |
| | Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli | Q33976746 |
| | Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance | Q33980535 |
| | The antimicrobial resistance crisis: causes, consequences, and management | Q34192579 |
| | Understanding the scientific issues embedded in the generic drug approval process. | Q34476718 |
| | Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem | Q34514304 |
| | Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model | Q34820573 |
| | Pharmacodynamic evaluation of the activities of six parenteral vancomycin products available in the United States | Q34922218 |
| | An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics. | Q34922257 |
| | Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin | Q34922857 |
| | Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability | Q35532853 |
| | Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model | Q35666429 |
| | Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits | Q36667020 |
| | Curing action of sodium dodecyl sulfate on a Proteus mirabilis R+ strain | Q36761255 |
| | Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. | Q36761826 |
| | Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem | Q37544589 |
| | Updated sequence information for TEM beta-lactamase genes. | Q39469834 |
| | The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli | Q39955443 |
| | The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam | Q40852062 |
| | Evolution of antibiotic resistance | Q40877493 |
| | Structural studies on tazobactam | Q41129847 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0155806 | |
| P577 | publication date | 2016-05-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam | |
| P478 | volume | 11 | |